To further validate the expression of CCR1 and CD163 in NALFD and HF and explore their diagnostic capacity, we performed validation and ROC curve analyses in HF (GSE26887 and GSE57345) and NAFLD (GSE126848 and GSE89632) datasets. Here, CD163 is linked to metabolic dysfunction-associated steatotic liver disease.